BNP Paribas Financial Markets’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $255K | Buy |
|
|||||
|
2022
Q2 | $78.7K | Sell |
|
|||||
|
2022
Q1 | $110K | Buy |
|
|||||
|
2021
Q4 | $63.1K | Buy |
|
|||||
|
2021
Q3 | $86.5K | Buy |
|
|||||
|
2021
Q2 | $26.6K | Sell |
|
|||||
|
2021
Q1 | $87K | Sell |
|
|||||
|
2020
Q4 | $95.6K | Sell |
|
|||||
|
2020
Q3 | $101K | Buy |
|
|||||
|
2020
Q2 | $35.3K | Sell |
|
|||||
|
2020
Q1 | $191K | Buy |
|
|||||
|
2019
Q4 | $146K | Sell |
|
|||||
|
2019
Q3 | $146K | Buy |
|
|||||
|
2019
Q2 | $147K | Sell |
|
|||||
|
2019
Q1 | $403K | Buy |
|
|||||
|
2018
Q4 | $37.7K | Sell |
|
|||||
|
2018
Q3 | $139K | Buy |
|
|||||
|
2018
Q2 | $133K | Sell |
|
|||||
|
2018
Q1 | $400K | Buy |
|
|||||
|
2017
Q4 | $414K | Buy |
|
|||||
|
2017
Q3 | $180K | Sell |
|
|||||
|
2017
Q2 | $195K | Buy |
|
|||||
|
2017
Q1 | $5.99K | Sell |
|
|||||
|
2016
Q4 | $17.5K | Sell |
|
|||||
|
2016
Q3 | $62.6K | Buy |
|
|||||
|
2016
Q2 | $16.5K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $98.2K | Sell |
|
|||||
|
2015
Q3 | $80.5K | Buy |
|
|||||
|
2015
Q2 | $30.1K | Buy |
|
|||||
|
2015
Q1 | $7.74K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $15.8K | Buy |
|
|||||
|
2014
Q2 | $3.69K | Buy |
|
|||||
|
2014
Q1 | $204 | Sell |
|
|||||
|
2013
Q4 | $1.71K | Buy |
|